CN Stock MarketDetailed Quotes

603392 Beijing Wantai Biological Pharmacy Enterprise

Watchlist
  • 65.32
  • -0.31-0.47%
Market Closed May 23 15:00 CST
82.84BMarket Cap646.73P/E (TTM)

Beijing Wantai Biological Pharmacy Enterprise Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-73.93%752.51M
-50.73%5.51B
-42.56%4.97B
-29.78%4.16B
-8.98%2.89B
94.51%11.19B
140.56%8.65B
201.92%5.93B
284.85%3.17B
144.25%5.75B
Operating revenue
-73.93%752.51M
-50.73%5.51B
-42.56%4.97B
-29.78%4.16B
-8.98%2.89B
94.51%11.19B
140.56%8.65B
201.92%5.93B
284.85%3.17B
144.25%5.75B
Other operating revenue
----
-6.56%17.3M
----
110.02%13.57M
----
-61.69%18.52M
----
-93.43%6.46M
----
181.98%48.34M
Total operating cost
-52.76%672.2M
-32.52%3.88B
-21.80%3.08B
-14.20%2.24B
-3.53%1.42B
68.85%5.75B
80.88%3.93B
128.51%2.61B
207.04%1.47B
114.41%3.4B
Operating cost
-16.30%202.78M
-32.32%792.12M
-34.40%591.63M
-36.59%406.03M
-25.81%242.26M
43.13%1.17B
80.55%901.85M
120.55%640.37M
153.82%326.55M
84.94%817.71M
Operating tax surcharges
-75.45%2.95M
-33.87%33.91M
-32.53%25.82M
-14.15%21.83M
4.28%12.01M
91.96%51.28M
149.89%38.27M
172.66%25.43M
254.97%11.52M
113.57%26.71M
Operating expense
-77.58%203.52M
-50.98%1.6B
-39.91%1.51B
-21.77%1.28B
-6.98%907.65M
92.49%3.25B
132.42%2.51B
192.29%1.63B
310.14%975.78M
144.66%1.69B
Administration expense
28.03%75M
50.15%352.63M
30.92%196.63M
19.66%120.59M
20.31%58.58M
28.90%234.85M
20.02%150.19M
27.12%100.77M
43.82%48.69M
56.57%182.2M
Financial expense
-21.72%-18.78M
-50.91%-92.98M
-20.18%-62.2M
-135.30%-47.44M
-352.72%-15.43M
-1,285.91%-61.61M
-5,230.01%-51.75M
-1,496.55%-20.16M
486.46%6.11M
-54.29%5.2M
-Interest expense (Financial expense)
-14.54%1.73M
-10.55%6.86M
2.17%5.9M
-17.84%3.91M
-20.03%2.02M
34.77%7.67M
82.76%5.77M
159.91%4.76M
731.91%2.53M
237.59%5.69M
-Interest Income (Financial expense)
3.08%-20.67M
-108.72%-87.98M
-175.13%-59.7M
-355.33%-41.19M
-993.65%-21.33M
-331.36%-42.15M
-192.73%-21.7M
-261.80%-9.05M
-40.50%-1.95M
-96.37%-9.77M
Research and development
-5.10%206.73M
9.00%1.2B
114.03%812.68M
98.64%463.43M
104.91%217.84M
61.19%1.1B
-16.25%379.7M
14.13%233.31M
35.79%106.31M
116.91%681.82M
Credit Impairment Loss
49.63%-35.02M
124.83%22.55M
79.15%-21.55M
50.15%-47.73M
15.84%-69.53M
-8.85%-90.8M
-60.38%-103.32M
-262.82%-95.74M
-496.06%-82.61M
-240.59%-83.42M
Asset Impairment Loss
23.57%-9.16M
-2,142.32%-459.73M
-26.93%-29.76M
-87.91%-33.04M
-671.65%-11.98M
31.29%-20.5M
29.06%-23.44M
-167.46%-17.58M
46.73%-1.55M
-2.35%-29.84M
Other net revenue
258.16%47.6M
-245.26%-230.61M
1,431.35%111.76M
126.36%15.38M
53.37%-30.1M
994.02%158.76M
84.88%-8.39M
-2,958.87%-58.36M
-838.23%-64.55M
-306.31%-17.76M
Fair value change income
-27.68%3.98M
147.13%24.66M
338.92%17.09M
2,975.63%12.3M
1,735.73%5.51M
35,565.87%9.98M
5,173.14%3.89M
3,735.35%400K
2,776.51%300K
-91.98%27.97K
Invest income
242.27%41.53M
173.86%98.9M
425.91%81.2M
497.62%33.66M
395.47%12.13M
221.72%36.11M
78.99%15.44M
9.15%5.63M
-11.72%2.45M
-17.50%11.22M
Asset deal income
----
270.40%221.62K
850.31%176.23K
199.53%304.51K
-111.94%-12.14K
108.29%59.83K
102.25%18.54K
177.39%101.66K
15.67%101.66K
-237.38%-721.59K
Other revenue
36.97%46.27M
-63.02%82.79M
-34.76%64.6M
2.15%49.88M
101.45%33.78M
163.52%223.91M
190.58%99.02M
62.97%48.83M
138.78%16.77M
77.86%84.97M
Operating profit
-91.08%127.92M
-74.96%1.4B
-57.42%2B
-40.56%1.94B
-12.14%1.43B
140.33%5.6B
244.71%4.71B
296.24%3.26B
384.52%1.63B
200.37%2.33B
Add:Non operating Income
-97.04%62.17K
98.14%2.29M
70.54%1.83M
114.78%1.38M
63,042.71%2.1M
75.73%1.16M
113.34%1.08M
95.39%643.91K
-84.54%3.32K
111.02%658.56K
Less:Non operating expense
3.59%2.34M
-28.63%10.35M
-0.31%3.98M
26.16%2.78M
297.61%2.26M
191.89%14.5M
508.48%3.99M
311.28%2.2M
866.79%568.94K
-55.09%4.97M
Total profit
-91.24%125.64M
-75.04%1.39B
-57.44%2B
-40.58%1.93B
-12.12%1.43B
140.20%5.58B
244.54%4.71B
296.15%3.26B
384.41%1.63B
204.03%2.32B
Less:Income tax cost
-102.29%-4.14M
-79.58%146.89M
-71.35%191M
-52.71%225.33M
-26.07%180.69M
193.71%719.39M
337.84%666.74M
408.19%476.48M
425.09%244.4M
196.40%244.93M
Net profit
-89.64%129.78M
-74.37%1.25B
-55.15%1.81B
-38.50%1.71B
-9.66%1.25B
133.90%4.86B
232.83%4.04B
281.73%2.78B
377.88%1.39B
204.95%2.08B
Net profit from continuing operation
-89.64%129.78M
-74.37%1.25B
-55.15%1.81B
-38.50%1.71B
-9.66%1.25B
133.90%4.86B
232.83%4.04B
281.73%2.78B
377.88%1.39B
204.95%2.08B
Less:Minority Profit
-47.91%4.08M
-100.92%-1.18M
-96.44%3.4M
-91.92%6.97M
-85.99%7.82M
120.80%127.51M
275.52%95.5M
1,215.16%86.29M
5,646.18%55.86M
1,098.60%57.75M
Net profit of parent company owners
-89.90%125.71M
-73.65%1.25B
-54.15%1.81B
-36.78%1.7B
-6.46%1.24B
134.28%4.74B
231.91%3.94B
273.24%2.69B
360.18%1.33B
198.59%2.02B
Earning per share
Basic earning per share
-89.90%0.1
-73.88%0.99
-54.89%1.43
-38.81%1.34
-34.44%0.99
64.78%3.79
134.81%3.17
167.07%2.19
214.58%1.51
100.00%2.3
Diluted earning per share
-89.90%0.1
-73.88%0.99
-54.89%1.43
-38.81%1.34
-34.44%0.99
64.78%3.79
134.81%3.17
167.07%2.19
214.58%1.51
100.00%2.3
Other composite income
Total composite income
-89.64%129.78M
-74.37%1.25B
-55.15%1.81B
-38.50%1.71B
-9.66%1.25B
133.90%4.86B
232.83%4.04B
281.73%2.78B
377.88%1.39B
204.95%2.08B
Total composite income of parent company owners
-89.90%125.71M
-73.65%1.25B
-54.15%1.81B
-36.78%1.7B
-6.46%1.24B
134.28%4.74B
231.91%3.94B
273.24%2.69B
360.18%1.33B
198.59%2.02B
Total composite income of minority owners
-47.91%4.08M
-100.92%-1.18M
-96.44%3.4M
-91.92%6.97M
-85.99%7.82M
120.80%127.51M
275.52%95.5M
1,215.16%86.29M
5,646.18%55.86M
1,098.60%57.75M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -73.93%752.51M-50.73%5.51B-42.56%4.97B-29.78%4.16B-8.98%2.89B94.51%11.19B140.56%8.65B201.92%5.93B284.85%3.17B144.25%5.75B
Operating revenue -73.93%752.51M-50.73%5.51B-42.56%4.97B-29.78%4.16B-8.98%2.89B94.51%11.19B140.56%8.65B201.92%5.93B284.85%3.17B144.25%5.75B
Other operating revenue -----6.56%17.3M----110.02%13.57M-----61.69%18.52M-----93.43%6.46M----181.98%48.34M
Total operating cost -52.76%672.2M-32.52%3.88B-21.80%3.08B-14.20%2.24B-3.53%1.42B68.85%5.75B80.88%3.93B128.51%2.61B207.04%1.47B114.41%3.4B
Operating cost -16.30%202.78M-32.32%792.12M-34.40%591.63M-36.59%406.03M-25.81%242.26M43.13%1.17B80.55%901.85M120.55%640.37M153.82%326.55M84.94%817.71M
Operating tax surcharges -75.45%2.95M-33.87%33.91M-32.53%25.82M-14.15%21.83M4.28%12.01M91.96%51.28M149.89%38.27M172.66%25.43M254.97%11.52M113.57%26.71M
Operating expense -77.58%203.52M-50.98%1.6B-39.91%1.51B-21.77%1.28B-6.98%907.65M92.49%3.25B132.42%2.51B192.29%1.63B310.14%975.78M144.66%1.69B
Administration expense 28.03%75M50.15%352.63M30.92%196.63M19.66%120.59M20.31%58.58M28.90%234.85M20.02%150.19M27.12%100.77M43.82%48.69M56.57%182.2M
Financial expense -21.72%-18.78M-50.91%-92.98M-20.18%-62.2M-135.30%-47.44M-352.72%-15.43M-1,285.91%-61.61M-5,230.01%-51.75M-1,496.55%-20.16M486.46%6.11M-54.29%5.2M
-Interest expense (Financial expense) -14.54%1.73M-10.55%6.86M2.17%5.9M-17.84%3.91M-20.03%2.02M34.77%7.67M82.76%5.77M159.91%4.76M731.91%2.53M237.59%5.69M
-Interest Income (Financial expense) 3.08%-20.67M-108.72%-87.98M-175.13%-59.7M-355.33%-41.19M-993.65%-21.33M-331.36%-42.15M-192.73%-21.7M-261.80%-9.05M-40.50%-1.95M-96.37%-9.77M
Research and development -5.10%206.73M9.00%1.2B114.03%812.68M98.64%463.43M104.91%217.84M61.19%1.1B-16.25%379.7M14.13%233.31M35.79%106.31M116.91%681.82M
Credit Impairment Loss 49.63%-35.02M124.83%22.55M79.15%-21.55M50.15%-47.73M15.84%-69.53M-8.85%-90.8M-60.38%-103.32M-262.82%-95.74M-496.06%-82.61M-240.59%-83.42M
Asset Impairment Loss 23.57%-9.16M-2,142.32%-459.73M-26.93%-29.76M-87.91%-33.04M-671.65%-11.98M31.29%-20.5M29.06%-23.44M-167.46%-17.58M46.73%-1.55M-2.35%-29.84M
Other net revenue 258.16%47.6M-245.26%-230.61M1,431.35%111.76M126.36%15.38M53.37%-30.1M994.02%158.76M84.88%-8.39M-2,958.87%-58.36M-838.23%-64.55M-306.31%-17.76M
Fair value change income -27.68%3.98M147.13%24.66M338.92%17.09M2,975.63%12.3M1,735.73%5.51M35,565.87%9.98M5,173.14%3.89M3,735.35%400K2,776.51%300K-91.98%27.97K
Invest income 242.27%41.53M173.86%98.9M425.91%81.2M497.62%33.66M395.47%12.13M221.72%36.11M78.99%15.44M9.15%5.63M-11.72%2.45M-17.50%11.22M
Asset deal income ----270.40%221.62K850.31%176.23K199.53%304.51K-111.94%-12.14K108.29%59.83K102.25%18.54K177.39%101.66K15.67%101.66K-237.38%-721.59K
Other revenue 36.97%46.27M-63.02%82.79M-34.76%64.6M2.15%49.88M101.45%33.78M163.52%223.91M190.58%99.02M62.97%48.83M138.78%16.77M77.86%84.97M
Operating profit -91.08%127.92M-74.96%1.4B-57.42%2B-40.56%1.94B-12.14%1.43B140.33%5.6B244.71%4.71B296.24%3.26B384.52%1.63B200.37%2.33B
Add:Non operating Income -97.04%62.17K98.14%2.29M70.54%1.83M114.78%1.38M63,042.71%2.1M75.73%1.16M113.34%1.08M95.39%643.91K-84.54%3.32K111.02%658.56K
Less:Non operating expense 3.59%2.34M-28.63%10.35M-0.31%3.98M26.16%2.78M297.61%2.26M191.89%14.5M508.48%3.99M311.28%2.2M866.79%568.94K-55.09%4.97M
Total profit -91.24%125.64M-75.04%1.39B-57.44%2B-40.58%1.93B-12.12%1.43B140.20%5.58B244.54%4.71B296.15%3.26B384.41%1.63B204.03%2.32B
Less:Income tax cost -102.29%-4.14M-79.58%146.89M-71.35%191M-52.71%225.33M-26.07%180.69M193.71%719.39M337.84%666.74M408.19%476.48M425.09%244.4M196.40%244.93M
Net profit -89.64%129.78M-74.37%1.25B-55.15%1.81B-38.50%1.71B-9.66%1.25B133.90%4.86B232.83%4.04B281.73%2.78B377.88%1.39B204.95%2.08B
Net profit from continuing operation -89.64%129.78M-74.37%1.25B-55.15%1.81B-38.50%1.71B-9.66%1.25B133.90%4.86B232.83%4.04B281.73%2.78B377.88%1.39B204.95%2.08B
Less:Minority Profit -47.91%4.08M-100.92%-1.18M-96.44%3.4M-91.92%6.97M-85.99%7.82M120.80%127.51M275.52%95.5M1,215.16%86.29M5,646.18%55.86M1,098.60%57.75M
Net profit of parent company owners -89.90%125.71M-73.65%1.25B-54.15%1.81B-36.78%1.7B-6.46%1.24B134.28%4.74B231.91%3.94B273.24%2.69B360.18%1.33B198.59%2.02B
Earning per share
Basic earning per share -89.90%0.1-73.88%0.99-54.89%1.43-38.81%1.34-34.44%0.9964.78%3.79134.81%3.17167.07%2.19214.58%1.51100.00%2.3
Diluted earning per share -89.90%0.1-73.88%0.99-54.89%1.43-38.81%1.34-34.44%0.9964.78%3.79134.81%3.17167.07%2.19214.58%1.51100.00%2.3
Other composite income
Total composite income -89.64%129.78M-74.37%1.25B-55.15%1.81B-38.50%1.71B-9.66%1.25B133.90%4.86B232.83%4.04B281.73%2.78B377.88%1.39B204.95%2.08B
Total composite income of parent company owners -89.90%125.71M-73.65%1.25B-54.15%1.81B-36.78%1.7B-6.46%1.24B134.28%4.74B231.91%3.94B273.24%2.69B360.18%1.33B198.59%2.02B
Total composite income of minority owners -47.91%4.08M-100.92%-1.18M-96.44%3.4M-91.92%6.97M-85.99%7.82M120.80%127.51M275.52%95.5M1,215.16%86.29M5,646.18%55.86M1,098.60%57.75M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg